Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/17/2011 | US20110280830 Albumin Fusion Proteins |
11/17/2011 | US20110280800 Il-1 binding proteins |
11/17/2011 | CA2800311A1 Anti-fgfr2 antibodies |
11/17/2011 | CA2799046A1 Il-1 binding proteins |
11/16/2011 | EP2386644A2 Expression system |
11/16/2011 | EP2386643A2 Expression system |
11/16/2011 | EP2386642A2 Expression system |
11/16/2011 | EP2386634A1 Sterol side chain-cleaving enzyme protein and use thereof |
11/16/2011 | EP2386575A2 Dual specificity antibodies and methods of making and using |
11/16/2011 | EP2386574A2 Polypeptide variants with altered effector function |
11/16/2011 | EP2386318A1 Targeted biocides |
11/16/2011 | EP2048233B1 MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME |
11/16/2011 | EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer |
11/16/2011 | EP1019439B1 Soluble single-chain t-cell receptor proteins |
11/16/2011 | CN1863921B Methods for expression and purification of immunotoxins |
11/16/2011 | CN1789416B Human artificial chromosome containing human antibody lambda light chain |
11/16/2011 | CN102245767A Immunoassay method for human CXCL1 protein |
11/16/2011 | CN102245763A Acidothermus celluloyticus xylanase |
11/16/2011 | CN102245637A Antibody against n-terminal region of beta-chain of hemoglobin |
11/16/2011 | CN102242176A Method for processing collagen peptide by using fish leftovers |
11/16/2011 | CN102242175A Method for preparing peanut protein active peptides by enzymolysis of mixed enzymes |
11/16/2011 | CN102242174A Method for preparing peanut short chain polypeptide with microwave coupling enzymatic method |
11/16/2011 | CN102242173A Extraction method for envelope protein of grouper iridovirus |
11/16/2011 | CN102242172A Method for extracting fish collagen from fish skin |
11/16/2011 | CN102242171A Flagellin extract and novel purpose thereof |
11/16/2011 | CN102242142A Method for increasing output of bacillus subtilis antibacterial peptide through knock-out of phrC gene |
11/16/2011 | CN102242137A Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
11/16/2011 | CN102242073A Method for preparing daptomycin by fermentation |
11/16/2011 | CN102241772A Antibody and diagnostic kit |
11/16/2011 | CN102241747A Humanlike elastin and production method thereof |
11/16/2011 | CN102241733A Deer ossein polypeptide chelated calcium and enteric capsule and preparation method of enteric capsule |
11/16/2011 | CN102240398A Edwardsiella tarda subunit vaccine and preparation method thereof |
11/16/2011 | CN102240397A Production of high mannose proteins in plant culture |
11/16/2011 | CN101691397B Nisin mutant protein, code gene thereof and application thereof |
11/16/2011 | CN101676401B Scorpion extract |
11/16/2011 | CN101628931B Antitumor antibiotics, pharmaceutically acceptable salts thereof, preparation method thereof and use thereof |
11/16/2011 | CN101065493B Enzymatic reactions in the presence of keto acids |
11/15/2011 | US8058512 Gene expression and production of TGF-β proteins including bioactive mullerian inhibiting substance from plants |
11/15/2011 | US8058508 Optimizing glycan processing in plants |
11/15/2011 | US8058502 Increasing lifespan by modulation of WWP-1 and UBC-18 |
11/15/2011 | US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL |
11/15/2011 | US8058406 Composition comprising antibodies to LINGO or fragments thereof |
11/15/2011 | US8058405 Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides |
11/15/2011 | US8058402 Antagonistic human LIGHT-specific human monoclonal antibodies |
11/15/2011 | US8058401 Immunogenic compositions and uses thereof |
11/15/2011 | US8058398 Modified G-CSF polypeptide |
11/15/2011 | US8058253 Growth hormone releasing hormone treatment to decrease cholesterol levels |
11/15/2011 | US8058242 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule |
11/15/2011 | US8058238 High purity lipopeptides |
11/15/2011 | US8058232 HMGB1 high affinity binding domain Box-A mutants |
11/15/2011 | US8058053 Modification of protein glycosylation in methylotrophic yeast |
11/15/2011 | US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
11/15/2011 | US8058044 Deactivation of linking moieties in antibody-enzyme conjugates |
11/15/2011 | US8058038 Aldolase and production process of substituted α-keto acids |
11/15/2011 | US8058029 Method for cloning and expression of StuI restriction endonuclease and StuI methylase in E. coli |
11/15/2011 | US8058028 Polynucleotide |
11/15/2011 | US8058027 Improved exogenous gene expression of biotherapeutic proteins and antibodies of better purity, efficiency |
11/15/2011 | US8058026 Prion and perchloric acid-soluble protein PSP specific proteolytic enzyme for use in treatment of water and municiple waste; bioremediation |
11/15/2011 | US8058008 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
11/15/2011 | US8057998 Isolated genomic polynucleotide fragments from chromosome 19 that encode human syntaxin |
11/15/2011 | CA2518569C Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
11/15/2011 | CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells |
11/15/2011 | CA2417871C Enhanced 2-keto-l-gulonic acid production |
11/15/2011 | CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination |
11/15/2011 | CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof |
11/15/2011 | CA2343979C Human interleukin-b50, therapeutic uses |
11/15/2011 | CA2267197C Isolation and use of motoneuronotrophic factors |
11/15/2011 | CA2257851C Modulators of tissue regeneration |
11/15/2011 | CA2171761C Eotaxin: eosinophil chemotactic cytokine |
11/15/2011 | CA2170641C Senescent cell-derived inhibitors of dna synthesis |
11/10/2011 | WO2011140484A1 Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis |
11/10/2011 | WO2011139349A1 Compositions for linking zinc finger modules |
11/10/2011 | WO2011138403A1 Use of a genetically modified cell line expressing functional asialoglycoprotein receptor in the production of sialylated glycoproteins |
11/10/2011 | WO2011138233A1 Method for producing recombinant proteins from plant hairy roots |
11/10/2011 | WO2011047262A4 Dual variable domain immunoglobulins and uses thereof |
11/10/2011 | US20110277181 Drought tolerant plants and related constructs and methods involving genes encoding dtp21 polypeptides |
11/10/2011 | US20110277178 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
11/10/2011 | US20110277047 Genetically Modified Non-Human Mammals and Cells |
11/10/2011 | US20110275569 Proteases targeting agents |
11/10/2011 | US20110275539 Substrate for selecting and specifically influencing the function of cells |
11/10/2011 | US20110275123 Compositions and methods for generating antibodies |
11/10/2011 | US20110275122 Thrombopoietic compounds |
11/10/2011 | US20110275121 Methods and Compositions for Production of Recombinant Protein in HBX-Expressing Mammalian Cells |
11/10/2011 | US20110275120 Fusion Proteins With Cleavable Spacers and Uses Thereof |
11/10/2011 | US20110275119 Methods for ribosomal synthesis of polypeptides containing unnatural n-terminal groups and applications thereof |
11/10/2011 | US20110275107 Long wavelength engineered fluorescent proteins |
11/10/2011 | US20110275063 Systems and methods of droplet-based selection |
11/10/2011 | US20110274711 Hla-g polypeptides and pharmaceutical uses thereof |
11/10/2011 | US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling |
11/10/2011 | US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
11/10/2011 | US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof |
11/10/2011 | US20110274692 Screening Methods |
11/10/2011 | US20110274691 Ferroportin antibodies and methods of use |
11/10/2011 | US20110274690 Compositions and methods for the diagnosis and treatment of tumor |
11/09/2011 | EP2385375A2 Development and use of fluorescent probes of unbound analytes |
11/09/2011 | EP2385132A1 Multimeric ligands with enhanced stability |
11/09/2011 | EP2385131A1 The use of a genetically modified cell line expressing functional asialoglycoprotein receptor in the production of highly sialylated glycoproteins |
11/09/2011 | EP2385130A1 Method for producing recombinant proteins from plant hairy roots |
11/09/2011 | EP2385125A2 Method of producing biologically active vitamin K dependent proteins by recombinant methods |
11/09/2011 | EP2385115A1 Expression vector for producing protein derived from foreign gene in large quantity using animal cells, and use thereof |